HIV Diagnostics Market: Government initiatives taken may drive the market for HIV diagnostics

Market Overview:

Acquired Immunodeficiency Syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). As the name suggests, HIV diagnosis tests are carried out to discover the presence of the virus. A blood test can make the HIV identification, saliva test, viral load test, although the first competent test results are achieved by Enzyme-Linked Immunosorbent Assay (ELISA) test originally and later by the Western Bloat Method. The ELISA test that is enzyme-linked immunosorbent assay uses the antibodies to spot the substance, and the western blot technique is utilized to discover anti –HIV antibodies in the human serum sample. According to WHO, HIV identification includes freestanding sites, testing services in health care facilities, some community-based approaches and HIV self-testing (HIVST).

Market Drivers and Restraints:

With the growing prevalence of HIV/AIDS globally and various national initiatives by countries to come up with the awareness of HIV in individuals has driven the expansion of the HIV Diagnostic Market. The region with lower acquisition rate where the individuals are not mindful of the transmission mode, unsafe sex and changing lifestyle are some of the vital reasons that results in some multiplied number of HIV incidents. To diminish the disease occurrence and increase life assurance, the government of several countries together with various Non-Governmental Organizations are concentrating on developing HIV diagnostics and making them easily accessible to the overall population. According to the WHO report, 2015, there is a 0.8% prevalence of HIV globally, and Sab-Saharan Africa remains the most severely affected area with 70% of individuals for the global population. For example, the unmet necessities in Asia and Africa region for HIV diagnosis, and the government initiatives taken within the region may drive the market for HIV diagnostics.

To know more, click on the link below:

https://marketdataforecast.com/market-reports/global-hiv-diagnostics-market

Report Segmented as:

By Product:

  • Consumables
    • Assays and Kits & Reagents
    • Other Consumables
  • Instruments
  • Software & Services

By Type:

  • Antibody Tests
    • HIV Screening Tests
      • Elisa
      • Rapid Tests
      • Home Accessories Dried Blood Spots
    • HIV-1 Antibody Confirmatory Tests
      • Western Blot Tests
      • Indirect Immunofluorescence Assays (IFA)
      • Line Immunoassays
      • Radio-Immunoprecipitation Assays
    • HIV-2 & Group O Diagnostic Tests
      • Blood Antibody Tests
      • DBS Tests
      • Line ImmunoAssay (HIV2)
    • Viral Identification Tests
    • P24 Antigen Tests
    • Qualitative PCR Tests
    • Viral Culture
    • CD4 Testing
    • Viral Load Testing
    • Early Infant Diagnostics

By End-user:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users

Geographical Analysis:

The global HIV diagnostics market by region includes North America, Asia Pacific, South Africa, Europe and the rest of the world. North America dominates the HIV diagnostics market because of supportive government initiatives and funding to increase HIV identification procedures and build awareness among the population and an increase in demand for HIV diagnosis products in North America. For the North-America region, US government is allocating important budget for research and development in the area of HIV/AIDS diagnosis, and favorable reimbursements policies in the region by the government is encouraging the individuals to take the HIV diagnostics test which is driving the HIV diagnostics market in this region. Asia Pacific is a rising market for HIV diagnostics, because of increasing patient population suffering from HIV/AIDS and to generate awareness among the people is pulling the HIV diagnostics market for this region.

Important Market Players:

The major players operating the HIV Diagnostics Market globally are Abbott Healthcare, BD Biosciences,  Zyomyx Incorporation, Roche Diagnostics,Merck & Company Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, Chembio Diagnostic Systems, Hologic Incorporation, Alere Incorporation, Qiagen,  VIIV healthcare, Sysmex Incorporation Gilead Sciences, Beckman Coulter  And many others. To increase the accessibility and portability key market players are comprised in the clinical exploration of CD4, viral load and antibody test for HIV diagnostic market.

View a sample and decide @ https://marketdataforecast.com/market-reports/global-hiv-diagnostics-market/request-sample

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/

Be the first to comment

Leave a Reply

Your email address will not be published.


*